Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 714.85 10.65  | 1.51% 28.05% 32.43 19,404.68
NSE Price: Oct 23 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 23 714.85 10.65 1.51% 709.90 704.20 52,671 707.00 - 716.75
BSE Oct 23 715.30 10.45 1.48% 711.00 704.85 3,858 708.45 - 718.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 750,943.61 P/B: 6.12 NSE Code: GLENMARK
52-Week Range: R 487.60 - 790.00 Dividend Yield: 0.28% BSE Code: 532296
TTM EPS: R 22.06 Book Value: R 116.79 Face Value: R 1
Price Graph
  • Glaxosmithkline Pharma (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. 33.90 1.01 20.77 28.05 34.83 24.89 25.09
S&P BSE Mid Cap* 42.80 -3.13 2.84 59.92 16.11 8.24 15.01
S&P BSE Healthcare* 38.90 -0.17 15.73 41.56 32.60 26.25 18.39
Company's return has been calculated on basis of NSE's price.
As on Oct 23, 2014
*As on Oct 22, 2014
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 19.64 26.32 23.30
Net Profit -13.16 6.02 23.04
EPS -12.66 6.04 21.18
Book Value 7.82 13.43 11.51
Average
Operating Margin 18.54 19.14 21.88
Net Margin 9.16 11.09 12.23
Return on Networth 18.99 21.41 20.37
Return on Investment 15.04 15.72 15.28
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 9.46 15.93 19.90
Operating Profit 12.45 13.75 48.14
Net Profit 36.25 0.60 26.20
EPS 40.09 1.42 29.51
TTM
Revenue 4.06 18.87 12.48
Operating Profit 3.87 20.60 17.57
Net Profit 0.19 11.01 7.87
EPS 0.46 11.18 8.24
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 19,404.68 2,407.93 419.96 17.02 18.99 6.12 32.43
Divi's Laboratories 24,028.89 2,639.48 784.94 28.95 28.31 7.50 30.61
Glaxosmithkline Pharma 22,947.32 2,533.55 412.66 15.25 24.10 10.37 55.61
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 22, 2014 Rajesh V Desai  Sell Market 2,000 720.55 14.41
Aug 06, 2014 Rajesh V Desai  Sell Market 15,000 666.70 100.01
May 27, 2014 Blanche Elizabeth Saldanha  Buy Market 9,700 520.80 50.52
Mar 06, 2014 Rajesh V Desai  Sell Market 25,651 574.85 147.45
Feb 28, 2014 Rajesh V Desai  Sell Market 4,743 569.65 27.02
Fund Houses which are invested in the stock
Fund Sep-14 Jun-14 Mar-14 Dec-13 Sep-13
ICICI Prudential Mutual Fund 0.352 0.035 0.049 0.074 0.038
UTI Mutual Fund 0.166 0.166 0.205 0.225 0.228
Kotak Mahindra Mutual Fund 0.109 - 0.029 0.121 0.032
Birla Sun Life Mutual Fund 0.104 0.400 0.596 0.734 0.536
DSP BlackRock Mutual Fund 0.084 - - - -
HSBC Mutual Fund 0.046 0.046 0.028 0.028 0.037
JM Financial Mutual Fund 0.046 - - - -
Mirae Asset Mutual Fund 0.043 0.022 0.024 0.024 0.023
HDFC Mutual Fund 0.038 0.038 0.400 0.480 0.623
Tata Mutual Fund 0.035 0.030 0.060 0.071 0.111
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: webmaster@glenmarkpharma.com

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad | Phone: 91-040-23420818 | Fax: 91-040-23420814

Email: mailmanager@karvy.com

Website: www.karvycomputershare.com